Clinical trial
Biologically Focused Therapy of Treatment Refractory MDS Patients
NCT05245032 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biologically Focused Therapy of Treatment Refractory MDS Patients
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 18, 2020
- Completion date
- December 1, 2022
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.